Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1709) 1709
science & technology (1514) 1514
life sciences & biomedicine (1427) 1427
male (837) 837
mycobacterium infections, nontuberculous - drug therapy (837) 837
female (835) 835
mycobacterium infections, nontuberculous - microbiology (732) 732
infectious diseases (689) 689
nontuberculous mycobacteria - drug effects (607) 607
middle aged (593) 593
adult (552) 552
biological and medical sciences (517) 517
microbiology (489) 489
medical sciences (465) 465
nontuberculous mycobacteria (459) 459
mycobacterium infections, nontuberculous - diagnosis (444) 444
anti-bacterial agents - therapeutic use (442) 442
nontuberculous mycobacteria - isolation & purification (433) 433
microbial sensitivity tests (428) 428
aged (395) 395
tuberculosis (322) 322
anti-bacterial agents - pharmacology (317) 317
health aspects (272) 272
infections (257) 257
immunology (245) 245
bacterial infections and mycoses (244) 244
treatment outcome (244) 244
bacterial diseases (243) 243
animals (241) 241
mycobacterium infections, nontuberculous - epidemiology (237) 237
bacteria (226) 226
respiratory system (225) 225
mycobacterium infections, nontuberculous - etiology (224) 224
mycobacterium - drug effects (209) 209
human bacterial diseases (193) 193
drug therapy, combination (182) 182
pharmacology & pharmacy (175) 175
mycobacterium abscessus (174) 174
retrospective studies (174) 174
risk factors (174) 174
research article (170) 170
abridged index medicus (169) 169
antitubercular agents - therapeutic use (168) 168
mycobacterium (165) 165
pharmacology. drug treatments (165) 165
adolescent (162) 162
general & internal medicine (162) 162
mycobacteria (161) 161
drug resistance, microbial (159) 159
antibacterial agents (157) 157
medicine (155) 155
tuberculosis and atypical mycobacterial infections (154) 154
lung diseases (153) 153
mycobacterium tuberculosis - drug effects (152) 152
antibiotics. antiinfectious agents. antiparasitic agents (149) 149
mycobacterium infections, nontuberculous - pathology (146) 146
care and treatment (142) 142
antibiotics (141) 141
mycobacterium chelonae - isolation & purification (140) 140
mycobacterium infections, nontuberculous - complications (140) 140
antitubercular agents - pharmacology (137) 137
research (136) 136
clarithromycin - therapeutic use (134) 134
patients (126) 126
dermatology (123) 123
infection (119) 119
cystic fibrosis (118) 118
mycobacterium infections, nontuberculous - therapy (118) 118
child (117) 117
nontuberculous mycobacteria - genetics (117) 117
mycobacterial infections (116) 116
aged, 80 and over (115) 115
tuberculosis, pulmonary - drug therapy (114) 114
drug resistance (112) 112
surgery (112) 112
diagnosis (110) 110
mycobacterium infections, nontuberculous - immunology (110) 110
bacterial infections (109) 109
drug resistance, bacterial (108) 108
lung diseases - microbiology (107) 107
nontuberculous mycobacteria - classification (106) 106
mycobacterium - isolation & purification (105) 105
young adult (102) 102
analysis (98) 98
sputum - microbiology (98) 98
medicine, general & internal (97) 97
mycobacterium avium complex (97) 97
mice (94) 94
mycobacterium tuberculosis (92) 92
anti-bacterial agents - administration & dosage (91) 91
mycobacterium chelonae (91) 91
mycobacterium chelonae - drug effects (90) 90
child, preschool (88) 88
epidemiology (87) 87
nontuberculous mycobacteria - growth & development (87) 87
science & technology - other topics (87) 87
clarithromycin (85) 85
immunocompromised host (85) 85
multidisciplinary sciences (85) 85
skin diseases, bacterial - microbiology (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2056) 2056
Japanese (85) 85
German (38) 38
French (35) 35
Spanish (35) 35
Russian (15) 15
Chinese (13) 13
Portuguese (10) 10
Polish (8) 8
Czech (4) 4
Dutch (3) 3
Italian (3) 3
Korean (2) 2
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
by Valentina La Rosa and Giovanna Poce and Julio Ortiz Canseco and Silvia Buroni and Maria Rosalia Pasca and Mariangela Biava and Ravikiran M. Raju and Giulio Cesare Porretta and Salvatore Alfonso and Claudio Battilocchio and Babak Javid and Flavia Sorrentino and Thomas R. Ioerger and James C. Sacchettini and Fabrizio Manetti and Maurizio Botta and Alessandro De Logu and Eric J. Rubin and Edda De Rossi
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2012, Volume 56, Issue 1, pp. 324 - 331
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Genomic Library | Mycobacterium tuberculosis - drug effects | Microbial Sensitivity Tests | Mycobacterium bovis - drug effects | Cattle | DNA Mutational Analysis | Membrane Transport Proteins - genetics | Mycobacterium Infections, Nontuberculous - microbiology | Carbonyl Cyanide m-Chlorophenyl Hydrazone - pharmacology | Drug Resistance, Multiple, Bacterial | Reserpine - pharmacology | Mycobacterium bovis - genetics | Genome, Bacterial | Mycobacterium smegmatis - genetics | Antitubercular Agents - pharmacology | Carbonyl Cyanide m-Chlorophenyl Hydrazone - analogs & derivatives | Piperazines - pharmacology | Verapamil - pharmacology | Pyrroles - pharmacology | Animals | Mycobacterium smegmatis - drug effects | Mutation | Mycobacterium Infections, Nontuberculous - drug therapy | Carbon Radioisotopes | Mycobacterium tuberculosis - genetics | Index Medicus | Piperazines | Mycobacterium bovis | Pyrroles | Mycobacterium smegmatis | Carbonyl Cyanide m-Chlorophenyl Hydrazone | Mycobacterium Infections, Nontuberculous | Life Sciences | Antitubercular Agents | Mycobacterium tuberculosis | Membrane Transport Proteins | Verapamil | Reserpine | Pharmaceutical sciences | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species, "mycobacterium virginiense" sp. Nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis
by Vasireddy, Ravikiran and Vasireddy, Sruthi and Brown-Elliott, Barbara A and Wengenack, Nancy L and Eke, Uzoamaka A and Benwill, Jeana L and Turenne, Christine and Wallace, Richard J
Journal of clinical microbiology, ISSN 0095-1137, 05/2016, Volume 54, Issue 5, pp. 1340 - 1351
Life Sciences & Biomedicine | Microbiology | Science & Technology | United States | Humans | Middle Aged | Antitubercular Agents - pharmacology | Male | Tenosynovitis - microbiology | DNA, Ribosomal - chemistry | Sequence Analysis, DNA | Mycobacterium - genetics | Microbial Sensitivity Tests | Mycobacterium - drug effects | Mycobacterium - isolation & purification | Young Adult | DNA-Directed RNA Polymerases | Mycobacterium Infections, Nontuberculous - microbiology | Osteomyelitis - microbiology | Mycobacterium - classification | RNA, Ribosomal, 16S - genetics | Adult | Female | Aged | DNA, Ribosomal - genetics | Index Medicus | Mycobacteriology and Aerobic Actinomycetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
by Dedrick, Rebekah M and Guerrero-Bustamante, Carlos A and Garlena, Rebecca A and Russell, Daniel A and Ford, Katrina and Harris, Kathryn and Gilmour, Kimberly C and Soothill, James and Jacobs-Sera, Deborah and Schooley, Robert T and Hatfull, Graham F and Spencer, Helen
Nature medicine, ISSN 1078-8956, 05/2019, Volume 25, Issue 5, pp. 730 - 733
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Genetic Engineering - methods | Cystic Fibrosis - microbiology | Mycobacterium Infections, Nontuberculous - microbiology | Humans | Adolescent | Drug Resistance, Bacterial | Mycobacterium Infections, Nontuberculous - therapy | Female | Phage Therapy - methods | Mycobacterium abscessus - drug effects | Bacteriophages | Case studies | Drug resistance in microorganisms | Usage | Care and treatment | Microbial genetic engineering | Cystic fibrosis | Mycobacterial infections | Health aspects | Methods | Intravenous administration | Syngeneic grafts | Phages | Lung transplantation | Transplantation | Genomes | Drug resistance | Patients | Nodules | Fibrosis | Genetics | Skin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases
by Huh, Hee Jae and Kim, Su-Young and Jhun, Byung Woo and Shin, Sung Jae and Koh, Won-Jung
Infection, genetics and evolution, ISSN 1567-1348, 08/2019, Volume 72, pp. 169 - 182
diagnosis | Mycobacterium avium complex | drug resistance | Mycobacterium abscessus | Nontuberculous mycobacteria | Mycobacterium kansasii | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Nontuberculous Mycobacteria - drug effects | Humans | Mycobacterium Infections, Nontuberculous - diagnosis | Mycobacterium avium Complex - genetics | Nontuberculous Mycobacteria - classification | Anti-Bacterial Agents - therapeutic use | Mycobacterium avium Complex - drug effects | Mycobacterium kansasii - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Mycobacterium kansasii - genetics | Anti-Bacterial Agents - pharmacology | Mycobacterium abscessus - genetics | Drug Resistance, Multiple, Bacterial - genetics | Mycobacterium abscessus - drug effects | Pathology, Molecular | Mycobacterium Infections, Nontuberculous - drug therapy | Nontuberculous Mycobacteria - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium Species
by Areeya Disratthakit and Norio Doi
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2010, Volume 54, Issue 6, pp. 2684 - 2686
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Levofloxacin | Species Specificity | Humans | Aza Compounds - pharmacology | Mycobacterium fortuitum - drug effects | Mycobacterium tuberculosis - drug effects | Quinolines - pharmacology | Microbial Sensitivity Tests | Mycobacterium - isolation & purification | Mycobacterium avium Complex - isolation & purification | Ofloxacin - pharmacology | Mycobacterium chelonae - isolation & purification | Drug Resistance, Multiple, Bacterial | Mycobacterium fortuitum - isolation & purification | Mycobacterium - classification | Mycobacterium Infections - microbiology | Mycobacterium chelonae - drug effects | Nontuberculous Mycobacteria - drug effects | Antitubercular Agents - pharmacology | Mycobacterium tuberculosis - isolation & purification | Mycobacterium - drug effects | Nontuberculous Mycobacteria - isolation & purification | Mycobacterium Infections - drug therapy | Mycobacterium avium Complex - drug effects | Mycobacterium kansasii - drug effects | Aminopyridines - pharmacology | Fluoroquinolones - pharmacology | Mycobacterium kansasii - isolation & purification | Rifampin - pharmacology | In Vitro Techniques | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
by Koh, Won-Jung and Jeon, Kyeongman and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Shin, Sung Jae and Huitt, Gwen A and Daley, Charles L and Kwon, O. Jung
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2011, Volume 183, Issue 3, pp. 405 - 410
Mycobacterium massiliense | Treatment outcome | Clarithromycin | Mycobacterium abscessus | Nontuberculous mycobacteria | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Sputum - microbiology | Cefoxitin - therapeutic use | Nontuberculous Mycobacteria - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Treatment Outcome | Clarithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - diagnosis | Microbial Sensitivity Tests | Amikacin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Antibiotics, Antitubercular - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis
by Buchieri, Maria V and Cimino, Mena and Rebollo-Ramirez, Sonia and Beauvineau, Claire and Cascioferro, Alessandro and Favre-Rochex, Sandrine and Helynck, Olivier and Naud-Martin, Delphine and Larrouy-Maumus, Gerald and Munier-Lehmann, Hélène and Gicquel, Brigitte
Journal of medicinal chemistry, ISSN 0022-2623, 09/2017, Volume 60, Issue 17, pp. 7425 - 7433
Nitroreductases - genetics | Mycobacterium smegmatis - genetics | Down-Regulation | Humans | Drug Resistance, Bacterial | Mycobacterium - genetics | Mycobacterium - drug effects | Mycobacterium Infections - drug therapy | Nitroreductases - metabolism | Mycobacterium Infections, Nontuberculous - microbiology | Anti-Bacterial Agents - chemistry | Mycobacterium smegmatis - drug effects | Mycobacterium - enzymology | Mycobacterium Infections - microbiology | Thiazoles - chemistry | Anti-Bacterial Agents - pharmacology | Thiazoles - pharmacology | Mycobacterium smegmatis - enzymology | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Mycobacterium | Mycobacterium smegmatis | Mycobacterium Infections | Mycobacterium Infections, Nontuberculous | Chemical Sciences | Life Sciences | Microbiology and Parasitology | Anti-Bacterial Agents | Nitroreductases | Thiazoles
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Microbiological features and clinical relevance of new species of the genus Mycobacterium
by Tortoli, Enrico
Clinical microbiology reviews, ISSN 0893-8512, 10/2014, Volume 27, Issue 4, pp. 727 - 752
Life Sciences & Biomedicine | Microbiology | Science & Technology | Mycobacterium Infections - epidemiology | Nontuberculous Mycobacteria - drug effects | Humans | Phylogeny | Mycobacterium Infections, Nontuberculous - epidemiology | Mycobacterium - genetics | Nontuberculous Mycobacteria - classification | Microbial Sensitivity Tests | Mycobacterium - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Mycobacterium - classification | Mycobacterium Infections - microbiology | Nontuberculous Mycobacteria - genetics | Index Medicus | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights